Helsinn Investment Fund

In the Group’s 40th year of operations, Helsinn has launched The Helsinn Investment Fund applying its fundamental core values of quality, integrity and respect, and drawing on 40 years’ expertise in research and development and commercialization of therapeutic candidates in cancer care, pain and inflammation and gastroenterology. The fund aims to help companies with innovative technologies transform new ideas into commercial solutions with the potential to positively impact health-related quality of life of patients.

For more information please visit http://helsinninvestmentfund.com/

 

Logo HIFrid